Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASIC3 | Q9UHC3 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.44 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.44 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | PRKACA | P17612 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | HTR7 | P34969 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31645963 | 1.00 | ASIC3 (0.59) | ASIC3NPC1RAB9AGABRA1GABRG2 | |
| SCHEMBL19614420 | 0.86 | GABRA1 (0.45) | ASIC3NPC1RAB9AGABRA1GABRG2 | |
| SCHEMBL1925061 | 0.85 | IDO1 (0.50) | ASIC3NPC1RAB9AGABRA1GABRG2 | |
| SCHEMBL16210551 | 0.84 | MEN1 (0.47) | ASIC3NPC1RAB9ANLRP3KDM4E | |
| SCHEMBL28580746 | 0.84 | ASIC3 (0.43) | ASIC3NPC1RAB9AGABRA1GABRG2 | |
| SCHEMBL26129711 | 0.84 | MEN1 (0.50) | ASIC3KDM4EALDH1A1SMN1; SMN2ADORA2A | |
| SCHEMBL31191934 | 0.84 | MEN1 (0.50) | ASIC3KDM4EALDH1A1SMN1; SMN2ADORA2A | |
| SCHEMBL26127676 | 0.83 | MEN1 (0.44) | ASIC3NPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL5760081 | 0.83 | SMN1; SMN2 (0.44) | ASIC3NPC1RAB9AKDM4EALDH1A1 | |
| SCHEMBL833371 | 0.81 | KDM4E (0.48) | KDM4EALDH1A1SMN1; SMN2GRM5LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | claimed |
| CN-113004194-B | Circular polarization luminescent organic micro-nano crystal material and preparation method and application thereof | 中国科学院化学研究所 | 2022-12-09 | — | — | CN | claimed |
| CN-113004191-B | White circular polarization luminescent organic micro-nano crystal material and preparation method thereof | 中国科学院化学研究所 | 2022-08-05 | — | — | CN | claimed |
| CN-110818834-B | Room-temperature phosphorescent material based on polymer hydrogen bonds and preparation method thereof | 南开大学 | 2021-06-29 | — | — | CN | claimed |
| CN-113004191-A | White circular polarization luminescent organic micro-nano crystal material and preparation method thereof | 中国科学院化学研究所 | 2021-06-22 | — | — | CN | claimed |
| CN-113004194-A | Circular polarization luminescent organic micro-nano crystal material and preparation method and application thereof | 中国科学院化学研究所 | 2021-06-22 | — | — | CN | claimed |
| CN-110818834-A | Room-temperature phosphorescent material based on polymer hydrogen bonds and preparation method thereof | 南开大学 | 2020-02-21 | — | — | CN | claimed |
| CN-104059630-B | A kind of novel red phosphorescence material and synthetic method thereof | 宁波大学 | 2016-06-15 | — | — | CN | claimed |
| US-20260125378-A2 | Heterocyclic Compounds | BEONE MEDICINES I GMBH (CH) | 2026-05-07 | — | — | US | disclosed |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-4658650-A1 | HETEROCYCLIC COMPOUNDS | Beone Medicines I GmbH (CH) | 2025-12-10 | — | — | EP | disclosed |
| US-20250353846-A1 | Heterocyclic Compounds | BEONE MEDICINES I GMBH (CH) | 2025-11-20 | — | — | US | disclosed |
| WO-2025215558-A1 | COMPOUNDS FOR SPLICING MODULATION | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | disclosed |
| WO-2007005404-A1 | AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION | WYETH (US) | 2007-01-11 | — | — | WO | disclosed |
| WO-2007005404-A1 | AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION | WYETH (US) | 2007-01-11 | — | — | WO | disclosed |
| US-20070004730-A1 | Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation | WYETH (US) | 2007-01-04 | — | — | US | disclosed |
| US-20070004730-A1 | Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation | WYETH (US) | 2007-01-04 | — | — | US | disclosed |
| US-20070004730-A1 | Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation | WYETH (US) | 2007-01-04 | — | — | US | disclosed |
| CN-1772838-A | Electroluminescent material of dendritic functional Ir (III) metal organic complex | UNIV XI AN JIAOTONG (CN) | 2006-05-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004730-A1 | Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation | BACE1, BACE2, APP | ASIC3 4086/4885NPC1 293/4885RAB9A 1731/4885 |
| US-20260125378-A2 | Heterocyclic Compounds | NFATC1, CD4, MALT1 | ASIC3 4696/4885NPC1 978/4885RAB9A 1314/4885 |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | ASIC3 1755/4885NPC1 1159/4885RAB9A 1211/4885 |
| US-20250353846-A1 | Heterocyclic Compounds | NFATC1, CD4, ACIN1 | ASIC3 4829/4885NPC1 1729/4885RAB9A 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.